Follow
Lloyd Harvey, MD, PhD
Lloyd Harvey, MD, PhD
Internal Medicine PGY-1, University of California Los Angeles
Verified email at mednet.ucla.edu
Title
Cited by
Cited by
Year
GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury
M Zonouzi, J Scafidi, P Li, B McEllin, J Edwards, JL Dupree, L Harvey, ...
Nature Neuroscience 18 (5), 674-682, 2015
1912015
Endothelial Dysfunction in Pulmonary Arterial Hypertension: An Evolving Landscape (2017 Grover Conference Series)
B Ranchoux, LD Harvey, RJ Ayon, A Babicheva, S Bonnet, SY Chan, ...
Pulmonary circulation, 2045893217752912, 2017
1442017
Administration of DHA reduces endoplasmic reticulum stress-associated inflammation and alters microglial or macrophage activation in traumatic brain injury
LD Harvey, Y Yin, IY Attarwala, G Begum, J Deng, HQ Yan, CE Dixon, ...
ASN Neuro 7 (6), 1759091415618969, 2015
992015
ER stress and effects of DHA as an ER stress inhibitor
G Begum, L Harvey, CE Dixon, D Sun
Translational Stroke Research 4 (6), 635-642, 2013
632013
Emerging Metabolic Therapies in Pulmonary Arterial Hypertension
LD Harvey, SY Chan
Journal of Clinical Medicine 6 (4), 43, 2017
482017
Simultaneous Pharmacologic Inhibition of Yes‐Associated Protein 1 and Glutaminase 1 via Inhaled Poly (Lactic‐co‐Glycolic) Acid–Encapsulated Microparticles Improves Pulmonary …
AP Acharya, Y Tang, T Bertero, YY Tai, LD Harvey, CSC Woodcock, ...
Journal of the American Heart Association 10 (12), e019091, 2021
152021
Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells
CSC Woodcock, N Hafeez, A Handen, Y Tang, LD Harvey, LE Estephan, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 320 (5 …, 2021
152021
YAPping about glutaminolysis in hepatic fibrosis
LD Harvey, SY Chan
Gastroenterology 154 (5), 1231-1233, 2018
62018
Evolving systems biology approaches to understanding non‐coding RNAs in pulmonary hypertension
LD Harvey, SY Chan
The Journal of Physiology 597 (4), 1199-1208, 2019
52019
Genetic regulation and targeted reversal of lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
LD Harvey, M Alotaibi, HJJ Kim, YY Tai, Y Tang, W Sun, W El Khoury, ...
bioRxiv, 2024.02. 26.582142, 2024
12024
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function
MK Culley, RJ Rao, M Mehta, J Zhao, W El Khoury, LD Harvey, D Perk, ...
Vascular Pharmacology 151, 107181, 2023
12023
GENETIC CONTROL OF LYSOSOMAL DYSFUNCTION REPROGRAMS INFLAMMATORY STEROL METABOLISM IN PULMONARY ARTERIAL HYPERTENSION
LD Harvey, HJ Kim, W Sun, W El Khoury, C St Croix, JY Lee, M Pauciulo, ...
Journal of the American College of Cardiology 83 (13_Supplement), 4600-4600, 2024
2024
Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension
M Alotaibi, LD Harvey, W Nichols, MW Pauciulo, AR Hemnes, T Long, ...
bioRxiv, 2024.01. 20.576474, 2024
2024
Genetic and Acquired DHCR7 Deficiency Upregulates 7β-hydroxycholesterol to Drive Endothelial Apoptosis and Pulmonary Hypertension
RJ Rao, HJ Kim, S Jiang, YY Tai, B Wang, Y Tang, W El Khoury, ...
Circulation 148 (Suppl_1), A17196-A17196, 2023
2023
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
SY Chan, LLD Harvey
US Patent 11,773,391, 2023
2023
Genetic Control of Lysosomal Dysfunction Reprograms Sterol Metabolism in Pulmonary Arterial Hypertension
LD Harvey, HJJ Kim, M Alotaibi, YY Tai, Y Tang, S Arshad, W Sun, H Wu, ...
Circulation 146 (Suppl_1), A10096-A10096, 2022
2022
NCOA7 Deficiency Reprograms Lysosomal Behavior and Sterol Metabolism to Promote Endothelial Dysfunction and Pulmonary Arterial Hypertension
LD Harvey
University of Pittsburgh, 2021
2021
The Role of EBP50 in Regulating Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension
A Gorelova
University of Pittsburgh, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–18